Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Scynexis Inc (SCYX)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Scynexis Inc.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1178253.
Total stock buying since 2014: $13,353,340.
Total stock sales since 2014: $4,804,695.
Total stock option exercises since 2014: $0.
Table 3. Detailed insider trading at Scynexis Inc (SCYX)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2024-09-12 | Angulo Gonzalez David (Chief Executive Officer) | Buy | 20,000 | 1.37 | 27,400 |
2022-04-26 | Sukenick Scott (General Counsel) | Buy | 3,500 | 3.00 | 10,500 |
2022-04-26 | Taglietti Marco (Chief Executive Officer) | Buy | 75,000 | 3.00 | 225,000 |
2021-01-22 | Edelman Joseph (10% Owner) | Sale | 319,000 | 8.55 | 2,729,045 |
2021-01-21 | Edelman Joseph (10% Owner) | Sale | 95,000 | 7.38 | 701,100 |
2021-01-20 | Edelman Joseph (10% Owner) | Sale | 185,000 | 7.43 | 1,374,550 |
2020-12-21 | Tinmouth Brian Philippe (Director) | Buy | 8,000 | 6.25 | 50,000 |
2020-12-21 | Sukenick Scott (General Counsel) | Buy | 1,600 | 6.25 | 10,000 |
2020-12-21 | Francois Eric (Chief Financial Officer) | Buy | 600 | 6.25 | 3,750 |
2020-12-21 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 1,600 | 6.25 | 10,000 |
2020-12-21 | Taglietti Marco (Chief Executive Officer) | Buy | 40,000 | 6.25 | 250,000 |
2020-12-21 | Gilman Steven C (Director) | Buy | 4,000 | 6.25 | 25,000 |
2020-12-21 | Macdonald Guy (Director) | Buy | 8,000 | 6.25 | 50,000 |
2020-12-21 | Hanham Ann (Director) | Buy | 3,200 | 6.25 | 20,000 |
2020-12-21 | Anido Armando (Director) | Buy | 5,000 | 6.25 | 31,250 |
2019-12-12 | Taglietti Marco (Chief Executive Officer) | Buy | 166,667 | .90 | 150,000 |
2019-08-21 | Taglietti Marco (Chief Executive Officer) | Buy | 9,500 | 1.11 | 10,545 |
2019-08-20 | Taglietti Marco (Chief Executive Officer) | Buy | 500 | 1.11 | 555 |
2019-08-15 | Taglietti Marco (Chief Executive Officer) | Buy | 10,015 | 1.01 | 10,115 |
2019-04-17 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 1.63 | 40,750 |
2019-01-10 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | .69 | 17,250 |
2018-12-31 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 12,000 | .50 | 5,952 |
2018-12-31 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | .46 | 11,500 |
2018-09-06 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 7,000 | 1.27 | 8,890 |
2018-08-23 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 1.29 | 32,250 |
2018-03-29 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 6,000 | 1.36 | 8,160 |
2018-03-08 | Sukenick Scott (General Counsel) | Buy | 2,959 | 1.69 | 5,000 |
2018-03-08 | Francois Eric (Chief Financial Officer) | Buy | 5,917 | 1.69 | 9,999 |
2018-03-08 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 21,790 | 1.54 | 34,725 |
2018-03-08 | Taglietti Marco (Chief Executive Officer) | Buy | 100,000 | 1.69 | 169,000 |
2018-03-08 | Hastings David C (Director) | Buy | 11,834 | 1.69 | 19,999 |
2017-09-22 | Taglietti Marco (Chief Executive Officer) | Buy | 10,000 | 2.23 | 22,300 |
2017-08-23 | Taglietti Marco (Chief Executive Officer) | Buy | 4,993 | 1.85 | 9,237 |
2017-08-22 | Taglietti Marco (Chief Executive Officer) | Buy | 7 | 1.61 | 11 |
2017-08-15 | Taglietti Marco (Chief Executive Officer) | Buy | 10,000 | 1.61 | 16,100 |
2017-08-11 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 10,000 | 1.55 | 15,500 |
2017-06-21 | Hastings David C | Buy | 20,000 | 1.75 | 35,000 |
2017-05-12 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 15,000 | 1.70 | 25,500 |
2017-05-12 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 1.69 | 42,250 |
2016-12-21 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 3.30 | 82,500 |
2016-12-16 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 4,000 | 3.25 | 13,000 |
2016-09-15 | Machado Patrick | Buy | 40,000 | 2.94 | 117,600 |
2016-06-30 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 32,150 | 2.23 | 71,694 |
2016-06-29 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 4,800 | 2.18 | 10,464 |
2016-06-24 | Francois Eric (Chief Financial Officer) | Buy | 15,000 | 2.39 | 35,850 |
2016-06-24 | Taglietti Marco (Chief Executive Officer) | Buy | 100,000 | 2.39 | 239,000 |
2016-06-24 | Machado Clarence Patrick | Buy | 20,000 | 2.39 | 47,800 |
2016-06-24 | Macdonald Guy | Buy | 40,000 | 2.39 | 95,600 |
2016-05-25 | Taglietti Marco (Chief Executive Officer) | Buy | 6,000 | 3.23 | 19,545 |
2016-05-25 | Hanham Ann | Buy | 4,225 | 3.64 | 15,379 |
2016-05-24 | Taglietti Marco (Chief Executive Officer) | Buy | 5,500 | 3.37 | 18,535 |
2016-05-23 | Taglietti Marco (Chief Executive Officer) | Buy | 3,000 | 3.15 | 9,450 |
2016-05-20 | Taglietti Marco (Chief Executive Officer) | Buy | 4,500 | 3.14 | 14,130 |
2016-05-19 | Taglietti Marco (Chief Executive Officer) | Buy | 6,000 | 3.07 | 18,420 |
2015-11-24 | Taglietti Marco (Chief Executive Officer) | Buy | 7,733 | 6.80 | 52,584 |
2015-11-23 | Taglietti Marco (Chief Executive Officer) | Buy | 15,000 | 6.79 | 101,850 |
2015-09-15 | Angulo Gonzalez David (Chief Medical Officer) | Buy | 3,000 | 7.00 | 21,000 |
2015-08-31 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 7.82 | 195,500 |
2015-08-28 | Taglietti Marco (Chief Executive Officer) | Buy | 400 | 7.15 | 2,860 |
2015-08-27 | Taglietti Marco (Chief Executive Officer) | Buy | 1,867 | 7.07 | 13,199 |
2015-08-26 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 6.98 | 174,500 |
2015-08-25 | Taglietti Marco (Chief Executive Officer) | Buy | 25,000 | 7.16 | 178,875 |
2014-05-07 | Ventech Capital Ii (10% Owner) | Buy | 28,000 | 10.00 | 280,000 |
2014-05-07 | F.c.p.r. Genavent (10% Owner) | Buy | 10,000 | 10.00 | 100,000 |
2014-05-07 | Fcpr Biotechnology Fund (10% Owner) | Buy | 50,000 | 10.00 | 500,000 |
2014-05-07 | Nothias Jean-yves (Director) | Buy | 50,000 | 10.00 | 500,000 |
2014-05-07 | Champsi Farah (10% Owner) | Buy | 900,000 | 10.00 | 9,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of SCYX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Scynexis Inc (symbol SCYX,
CIK number 1178253) see
the Securities and Exchange Commission (SEC) website.